Improved Outcome of Elderly Patients (≥75 Years of Age) With Acute Myocardial Infarction From 1981-1983 to 1992-1994 in Israel
- 21 January 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 95 (2) , 342-350
- https://doi.org/10.1161/01.cir.95.2.342
Abstract
Background The number of elderly patients experiencing acute myocardial infarction (AMI) is growing rapidly, and their hospital mortality rate remains high, although mortality after AMI declined in the 1990s with the introduction of new therapeutic modalities. Methods and Results We compared the management, in-hospital complications, and 30-day and 1-year mortality rates in two cohorts of elderly (≥75 years of age) AMI patients in the coronary care units in Israel before and after the reperfusion era. The first cohort of 789 consecutive patients was from the Secondary Prevention Reinfarction Israel Nifedipine Trial registry in 1981-1983; the second 366 patients came from two prospective nationwide surveys in 1992 and 1994. Reperfusion therapies were not used in 1981-1983 but were used in 1992-1994. The 30-day mortality rate declined from 38% in 1981-1983 to 27% in 1992-1994 (odds ratio, 0.49; 95% confidence interval [CI], 0.34 to 0.71), and the cumulative 1-year mortality rate declined from 52% to 38% (hazard ratio [HR], 0.62; 95% CI, 0.50 to 0.76). In the 1992-1994 cohort, the decline in mortality was most marked in patients reperfused by thrombolysis and/or percutaneous transluminal coronary angioplasty or coronary artery bypass graft surgery but was also evident in nonreperfused patients: cumulative 1-year mortality rate was 29% in the former (HR, 0.45; 95% CI, 0.31 to 0.67) and 42% in the latter (HR, 0.60; 95% CI, 0.46 to 0.78). Conclusions During the last decade, elderly (≥75 years) AMI patients experienced fewer in-hospital complications and lower 30-day and 1-year mortality rates, which declined ≈30%, most markedly in reperfused patients. The favorable outcome in 1992-1994 was related to changes in patient management. Reperfusion therapy is therefore also advocated in elderly AMI patients, unless specific contraindications are present.Keywords
This publication has 42 references indexed in Scilit:
- Improved survival of hospitalized patients with acute myocardial infarction from 1981–1983 to 1992 in IsraelCoronary Artery Disease, 1994
- Influence of gender in the therapeutic management of patients with acute myocardial infarction in IsraelThe American Journal of Cardiology, 1994
- Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patientsPublished by Elsevier ,1994
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- Optimal utilization of thrombolytic therapy for acute myocardial infarction: Concepts and controversiesJournal of the American College of Cardiology, 1990
- Comparison of Invasive and Conservative Strategies after Treatment with Intravenous Tissue Plasminogen Activator in Acute Myocardial InfarctionNew England Journal of Medicine, 1989
- Factors leading to shorter survival after acute myocardial infarction in patients ages 65 to 75 years compared with younger patientsThe American Journal of Cardiology, 1988
- Incidence and case fatality rates of acute myocardial infarction (1975–1984): The Worcester Heart Attack StudyAmerican Heart Journal, 1988
- Introductory remarks. IJournal of the American College of Cardiology, 1987
- Mortality and morbidity rates of patients older and younger than 75 years with acute myocardial infarction treated with intravenous streptokinaseThe American Journal of Cardiology, 1987